Zhejiang Hisun Pharmaceutical 483, Mar 2015

Zhejiang Hisun Pharmaceutical 483, Mar 2015

Peter Baker FDA, Gang Wang FDA$119.00

FDA investigators audited the Zhejiang Hisun Pharmaceutical facility in Taizhou, China and issued inspectional observations (via FDA 483) on 07 Mar 2015.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 07 Mar 2015
  • Location: Taizhou, China